When a less-than-truckload client came to Strick Trailers with an idea to build a more efficient and productive pup trailer, Strick delved into the task and came up with the Elevator. ...
Yahoo Finance’s Dan Howley joins the On The Move panel to break down the details of Apple’s new COVID-19 app. The tech giant partnered with the CDC and White House to create the app. ...
After a stunning fall to $10, shares of American Airlines (NASDAQ:AAL) have since been on a tear. Note that AAL stock is now at $15. Yet despite this rally, the company still sports a miserable year-to-date loss of 50%.Source: GagliardiPhotography / Shutterstock.com The volatility is certainly understandable as it is extremely difficult to gauge the future of American Airlines. The big issue, of course, is how long the depressed levels of travel will last. The coronavirus from China is a global menace. So just in terms of foreign travel, it could easily be several months or more with little revenue generation for AAL.Another issue is that the coronavirus may be seasonal. On Wednesday, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, said: "I know we'll be successful in putting this down now, but we really need to be prepared for another cycle."InvestorPlace - Stock Market...
The world is progressing towards a vaccine for the coronavirus with multiple large-scale and properly controlled studies exploring the efficacy of hydroxychloroquine, Novartis AG (NYSE: NVS) CEO Vas Narasimhan said on CNBC.Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.Narasimhan said ongoing studies consist of giving doses of hydroxychloroquine to hospitalized patients and other people who may have been exposed to the coronavirus. The trials are moving at a rapid pace, including a Novartis-sponsored study and other investigative trials and "a lot more data" should come out within the following month.Narasimhan said it's already known from pre-clinical studies involving animals so far have shown that hydroxychloroquine is "quite active against the coronavirus." Meanwhile, the drug is currently being used across the world as doctors are vying to give patients "any option they can."Why It's ImportantIt's too early to...
(Bloomberg) -- The American shale industry shocked the world with its rebound after the 2014-2016 bust, setting records for output that pushed the U.S. to the top spot among oil-producing countries. A handful of experts is saying that will happen again.The comeback trail would be steep and long. The spread of coronavirus is crushing demand while Saudi Arabia and Russia are creating a glut. Everybody agrees U.S. production will take a bigger hit than last time, when it dipped before soaring. As many as 70% of the 6,000 shale drillers may go bankrupt, and one-third of shale-patch workers are expected to lose their jobs. Wall Street, which financed the last boom, has cut off the cash spigot.But some experts are saying the future, however far off, will be better. They’re looking past the dire forecasts and vertical chart lines and cautioning against despair. They’re echoing a widespread view that’s mostly unspoken...
